|
|
||||||||
News in Physiological Sciences, Vol 10, 198-204, Copyright © 1995 by International Union of Physiological Sciences
ARTICLES |
MC Farach-Carson and RE Devoll
1a, 25-Dihydroxyvitamin D3 [1,25(OH)2D3] is a potential therapeutic agent for treatment of many clinical disorders, but its tendency to produce hypercalcemia at therapeutic dosages is a barrier to its usefulness. Derivatives of 1,25(OH)2D3 have been synthesized that possess the beneficial genomic activities of 1,25(OH)2D3 but have reduced nongenomic effects, which may be correlated with a tendency to produce hypercalcemia.
This article has been cited by other articles:
![]() |
R. Liu, W. Li, N. J. Karin, J. J. Bergh, K. Adler-Storthz, and M. C. Farach-Carson Ribozyme Ablation Demonstrates That the Cardiac Subtype of the Voltage-sensitive Calcium Channel Is the Molecular Transducer of 1,25-Dihydroxyvitamin D3-stimulated Calcium Influx in Osteoblastic Cells J. Biol. Chem., March 17, 2000; 275(12): 8711 - 8718. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |